Cargando…

In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study

OBJECTIVE: To evaluate differences in time in therapeutic range (TTR), major bleeding, thromboembolism, and survival comparing in-home and in-clinic international normalized ratio monitoring for patients with mechanical heart valves receiving warfarin anticoagulation. PATIENTS AND METHODS: An observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Zyl, Martin, Wysokinski, Waldemar E., Jaeger, Thomas M., Casanegra, Ana I., Gersh, Bernard J., McBane, Robert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560573/ https://www.ncbi.nlm.nih.gov/pubmed/33083699 http://dx.doi.org/10.1016/j.mayocpiqo.2020.05.003

Ejemplares similares

Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Gaddh, Manila, et al.
Publicado: (2023)

Accuracy and Prediction of D-Dimers for Pulmonary Embolism in Patients with COVID-19 Infection
por: Houghton, Damon E., et al.
Publicado: (2022)

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015)

A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
por: Joppa, Stephanie A., et al.
Publicado: (2018)

P1645: IMPACT OF VON WILLEBRAND FACTOR AND ADAMTS13 ON CARDIOVASCULAR COMPLICATIONS AND BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND NORMAL SINUS RHYTHM CONTROLS: 10 YEARS FOLLOW UP.
por: Wysokinski, Waldemar, et al.
Publicado: (2023)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
por: Cambron, Julia C., et al.
Publicado: (2020)

Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19–Positive Compared With COVID-19–Negative Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Thromboinflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 Patients
por: Chaudhary, Rahul, et al.
Publicado: (2021)

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis
por: Riaz, Irbaz Bin, et al.
Publicado: (2023)

Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes
por: Brunton, Nichole E., et al.
Publicado: (2021)

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
por: Guimarães, Patricia O., et al.
Publicado: (2019)

Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study
por: Durães, André R., et al.
Publicado: (2018)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

A patient-centered approach to the development and pilot of a warfarin pharmacogenomics patient education tool for health professionals
por: Barajas, Megan R., et al.
Publicado: (2015)

An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy
por: Kaufman, Adrienne, et al.
Publicado: (2021)

Factors Affecting Medication Adherence in Patients with Mechanical Heart Valves Taking Warfarin: The Role of Knowledge on Warfarin, Medication Belief, Depression, and Self-Efficacy
por: Park, Soohyun, et al.
Publicado: (2021)

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation
por: Jaffer, Iqbal H, et al.
Publicado: (2015)

The effects of Ramadan fasting on patients with prosthetic heart valve taking warfarin for anticoagulation
por: Awiwi, Muhammad O., et al.
Publicado: (2017)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
por: Wysokinski, Waldemar E., et al.
Publicado: (2020)

Thromboembolism and the Pandemic
por: McBane, Robert D.
Publicado: (2020)

Arterial Thrombosis and Coronavirus Disease 2019
por: McBane, Robert D.
Publicado: (2021)

New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model
por: Zhu, Zhihui, et al.
Publicado: (2019)

Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19
por: Pasha, Ahmed K., et al.
Publicado: (2021)

P1657: CANCER-ASSOCIATED NON-BACTERIAL THROMBOTIC ENDOCARDITIS AFFECTING RIGHT HEART VALVES AS POTENTIAL CAUSE OF PULMONARY EMBOLISM
por: Wysokinska, Ewa, et al.
Publicado: (2023)

Warfarin and Thrombotic Mechanical Aortic Valve – Be Cautious to Avoid Severe Warfarin Drug Interactions in Patients with Suspected Infective Endocarditis after Mechanical Aortic Valve Replacement [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2023)

Verification of Pharmacogenetics-Based Warfarin Dosing Algorithms in Han-Chinese Patients Undertaking Mechanic Heart Valve Replacement
por: Zhao, Li, et al.
Publicado: (2014)

Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
por: Liu, Rui, et al.
Publicado: (2017)

Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement
por: Wang, Xiaowu, et al.
Publicado: (2018)

A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement
por: Zhang, Fan, et al.
Publicado: (2022)

Chromogenic Factor X Assay for Monitoring Warfarin Anticoagulation in a Child With a Prosthetic Mitral Valve
por: Greenmyer, Jacob R., et al.
Publicado: (2021)

Intramural Esophageal Hematoma Mimicking Acute Coronary Syndrome: Complication of Warfarin Use in a Mechanical Heart Valve Patient
por: Alirezaei, Toktam, et al.
Publicado: (2022)

Combining portable coagulometers with the Internet: A new model of warfarin anticoagulation in patients following mechanical heart valve replacement
por: Huang, Yu, et al.
Publicado: (2022)

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022)

Optimal INR level for warfarin therapy after mechanical mitral valve replacement
por: Kamthornthanakarn, Itthidet, et al.
Publicado: (2019)

Anticoagulation in a Patient With Mechanical Prosthetic Valves and Calcific Uremic Arteriolopathy on Warfarin
por: Smith, Megan C, et al.
Publicado: (2021)

In-Home Cardiovascular Monitoring System for Heart Failure: Comparative Study
por: Conn, Nicholas J, et al.
Publicado: (2019)

Relative Expression of PBMC MicroRNA-133a Analysis in Patients Receiving Warfarin After Mechanical Heart Valve Replacement
por: Kabiri Rad, Hamid, et al.
Publicado: ( 201)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?
por: Teruel, Reyes Serrano, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aqe2ft1je57cbnnsd3frr2rpi8